How to Invest in Healthcare in Saudi Arabia

Saudi Arabia spends approximately 7 percent of GDP on healthcare, with the government committed to transforming a predominantly public system into one with significant private sector participation. Vision 2030’s Health Sector Transformation Programme targets expanding private healthcare’s share to 35 percent, creating a multi-billion-dollar investment opportunity. The Kingdom’s young, growing population and rising chronic disease prevalence ensure sustained demand growth.

Market Overview

Saudi Arabia’s healthcare market exceeds USD 40 billion annually and is growing at 5-7 percent per year. The Ministry of Health operates the majority of hospitals and primary care facilities but is actively pursuing privatisation and public-private partnerships. The National Health Insurance Council oversees mandatory health insurance implementation, which drives patients toward private providers.

Investment Routes

Hospital Development and Operations. Saudi Arabia plans to add thousands of hospital beds through private investment. International hospital groups including Johns Hopkins, Cleveland Clinic, and Mayo Clinic have partnerships or advisory roles. The National Unified Procurement Company (NUPCO) centralises medical procurement, creating scale efficiencies.

Pharmaceuticals and Biotech. The Kingdom aims to localise 40 percent of pharmaceutical production by 2030. The Saudi Food and Drug Authority (SFDA) has streamlined drug registration processes. Opportunities include generic manufacturing, vaccine production, biologics, and contract research organisations. KAUST and other research institutions provide R&D partnership possibilities.

Medical Devices. Saudi Arabia imports the majority of medical devices. Local manufacturing is incentivised through procurement preferences and MISA-facilitated investment. Devices for chronic disease management (diabetes, cardiovascular) are in particular demand.

Health Technology. Telehealth adoption accelerated during the COVID-19 pandemic and continues growing. Digital health platforms, electronic health records, AI-assisted diagnostics, remote patient monitoring, and hospital information systems represent significant opportunities.

Insurance. Mandatory health insurance expansion increases the insured population steadily. Foreign insurance companies can enter through joint ventures or wholly-owned subsidiaries. Health insurance premiums have grown at double-digit rates.

Privatisation. The government has announced plans to convert public hospitals into independent entities and eventually privatise select facilities. Healthcare PPP models are being developed for new hospital and primary care facility construction.

Regulatory Framework

The Ministry of Health oversees sector strategy. The SFDA regulates pharmaceuticals, medical devices, and food safety. The Council of Health Insurance manages insurance regulation. MISA issues foreign investment licences with 100 percent foreign ownership permitted in most healthcare sub-sectors.

Clinical licensing requires Saudi Commission for Health Specialties (SCFHS) accreditation for healthcare professionals. Hospital accreditation follows the Central Board for Accreditation of Healthcare Institutions (CBAHI) standards.

Fiscal Considerations

Foreign healthcare companies pay 20 percent corporate income tax. Healthcare services are zero-rated for VAT purposes, though medical devices and pharmaceuticals are subject to standard 15 percent VAT. Government incentives include subsidised land for hospital development and financing through the Human Resources Development Fund for workforce training.

Key Challenges

Healthcare workforce recruitment and Saudisation remain primary challenges. Saudi Arabia competes globally for nurses, allied health professionals, and specialist physicians. Regulatory approval timelines for new drugs and devices can be lengthy. Managing the transition from public to private payment models requires careful financial planning.

Getting Started

MISA provides investment licensing. The Ministry of Health facilitates healthcare facility licensing. The SFDA handles product registration. Private hospital developers should engage early with CBAHI for accreditation requirements. Healthcare PPP opportunities are announced through the National Centre for Privatisation and PPP (NCP).

Saudi Arabia’s healthcare transformation is among the most ambitious public-to-private transitions in any emerging market. The combination of growing demand, government reform commitment, and insurance expansion creates a structurally attractive investment environment.

See our Healthcare Sector Profile and Health Sector Transformation Tracker.